Arax Advisory Partners’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11K | Buy |
182
+160
| +727% | +$9.7K | ﹤0.01% | 1913 |
|
2025
Q1 | $1.61K | Sell |
22
-134
| -86% | -$9.81K | ﹤0.01% | 2138 |
|
2024
Q4 | $12.9K | Hold |
156
| – | – | ﹤0.01% | 1396 |
|
2024
Q3 | $11.2K | Sell |
156
-10
| -6% | -$715 | ﹤0.01% | 1359 |
|
2024
Q2 | $11.4K | Buy |
166
+158
| +1,975% | +$10.8K | ﹤0.01% | 1207 |
|
2024
Q1 | $430 | Hold |
8
| – | – | ﹤0.01% | 1243 |
|
2023
Q4 | $427 | Sell |
8
-14
| -64% | -$747 | ﹤0.01% | 1234 |
|
2023
Q3 | $1.09K | Hold |
22
| – | – | ﹤0.01% | 1107 |
|
2023
Q2 | $1.31K | Buy |
22
+4
| +22% | +$238 | ﹤0.01% | 1059 |
|
2023
Q1 | $1.02K | Sell |
18
-315
| -95% | -$17.9K | ﹤0.01% | 1097 |
|
2022
Q4 | $24.7K | Buy |
333
+108
| +48% | +$8.02K | ﹤0.01% | 538 |
|
2022
Q3 | $13K | Sell |
225
-10
| -4% | -$578 | ﹤0.01% | 625 |
|
2022
Q2 | $13K | Buy |
235
+201
| +591% | +$11.1K | ﹤0.01% | 616 |
|
2022
Q1 | $3K | Sell |
34
-7
| -17% | -$618 | ﹤0.01% | 878 |
|
2021
Q4 | $3K | Buy |
41
+23
| +128% | +$1.68K | ﹤0.01% | 839 |
|
2021
Q3 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 906 |
|